Skip to main content
Screener/Healthcare/Biotechnology

ACRV Acrivon Therapeutics, Inc. Common Stock

NASDAQ
$2.05+0.20 (+10.81%)
$1.05
$3.56
$1.86
$2.06
EPS (TTM)$-2.02
P/E Ratio-0.94
Dividend Yield
Market Cap$59.3M
Volume723K
Prev Close$1.85
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$0-$19.0M$-0.49
Q3 '25$0-$18.2M$-0.47
Q2 '25$0-$21.0M$-0.55
Q1 '25$0-$19.7M$-0.51
Q4 '24$0-$22.8M$-0.60
Q3 '24$0-$22.4M$-0.59
Q2 '24$0-$18.8M$-0.52
Q1 '24$0-$16.5M$-0.73
Get Your Daily Market Recap